The recommendation comes after a review by the UK drugs regulator found that by the end of March, seventy-nine people had suffered rare blood clots after vaccination – nineteen of whom had died.
Still, the regulator maintained that this was not proof the jab had caused the clots – although this sentence stood out starkly: “But (they) said the link was getting firmer”.
In any case, the review by the Medicines and Healthcare products Regulatory Agency (MHRA) found:
- The 79 cases and 19 deaths occurred after 20 million doses were administered – giving a risk of about four in one million of developing a blood clot, and one in a million of dying.
- Nearly two-thirds of the cases of rare clots were seen in women.
- The people who died were aged between 18 and 79, with three of them aged under 30.
All the recorded cases occurred after the first dose, although the lower number of second doses meant it was not possible to draw any conclusions from this.
Meanwhile, the EU's medicines regulator say unusual blood clots should be listed as a possible very rare side effect of the AstraZeneca jab, but that the benefits outweighed the risks. Some European countries have already restricted the vaccine's use.
And the World Health Organization said the link between the vaccine and blood clots was "plausible" but not confirmed, adding that the clotting incidents were "very rare" among nearly 200 million people who have received the jab worldwide.
Notwithstanding the benefits of the so-called AstraZeneca vaccine, there had unmistakably been deaths.
Therefore, it’s best to avoid this particular vaccine; after all, there are other vaccines that are an even better bet, especially the Chinese vaccines.
No comments:
Post a Comment